Qiagen N.V.

  • WKN: A2DKCH
  • ISIN: NL0012169213
  • Land: The Netherlands

Nachricht vom 06.05.2019 | 22:02

QIAGEN N.V.: Ad hoc Announcement according to Art. 17 Market Abuse Regulation QIAGEN to conduct an additional up to $100 million share repurchase program

QIAGEN N.V. / Key word(s): Share Buyback
QIAGEN N.V.: Ad hoc Announcement according to Art. 17 Market Abuse Regulation QIAGEN to conduct an additional up to $100 million share repurchase program

06-May-2019 / 22:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Key word: Share Repurchase Program

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

 

QIAGEN to conduct an additional up to $100 million share repurchase program

 

Venlo, The Netherlands, May 6, 2019 - QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has today passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 19, 2018, and to purchase shares in the Company up to a total of $100 million (or the equivalent Euro amount thereof, in each case excluding transaction costs). Based on the closing price on May 3, 2019, this represents a repurchase volume of approximately 2.5 million shares. The repurchase program is scheduled to begin at the earliest after completion of the current share repurchase program that was announced through an ad hoc announcement on January 31, 2018, and to be completed on December 19, 2019, at the latest, or if the upcoming General Meeting of Shareholders will extend the authorization to repurchase shares, on December 17, 2020, at the latest. Details of the repurchase program will be announced before its actual commencement in line with Article 5 Section (1) and (6) of the EU regulation 596/2014 in conjunction with the regulatory technical standards adopted by the European Commission (so called Safe Harbour Regulation). Repurchased shares will be held in treasury in order to satisfy obligations from employee share-based remuneration plans.

QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

The Netherlands

ISIN: NL0012169213

Frankfurt Stock Exchange, Regulated Market (Prime Standard)

Contacts QIAGEN N.V.:

Corporate Communications

John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com

Thomas Theuringer, Tel: +49 2013 29 11826 pr@qiagen.com


06-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG startet Aktienrückkaufprogramm in Höhe von bis zu 200 Mio. EUR

18. Oktober 2019, 16:04

Aktuelle Research-Studie

ad pepper media International N.V.

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Hinzufügen

18. Oktober 2019